poster

Listen to the Latest Episode

Subscribe

All Episodes

A Texas Hospital's ICU Department As Cases Near 10 Million In U.S.
By John Lauerman
On the outside, city hospitals look just as they always have: big glass and steel buildings, an ER entrance with ambulances coming and going. But on the inside, Covid has completely transformed the hospital experience for patients, their families -- and for doctors and hospital staff.
Modern syringe with liquid drug. The most anticipated procedure of the year
By Kristen V Brown
Even as much of the U.S. gets in line for a shot, many people’s reluctance has been decades in the making.
RF baby
By John Tozzi
The average cost of having a baby in the United States is $11,000 for people on private health insurance. But the price tag can vary by tens of thousands of dollars, depending on what hospital you go to and what doctor you see.
Why Silicon Valley Injected $300 Million Into a N.J. Health Care Business
By John Tozzi
The medical community is increasingly examining the role that poverty and difficult social circumstances play in illness. Some people are asking whether the health care system could do more to address the things that influence people’s health beyond their medical care.
The Startups Waging War Against Superbugs
By Jason Gale
Pills we’ve relied on for decades to treat common infections simply no longer work. It’s a silent yet full-blown crisis. Yet it’s not too late. With enough will and money, the world can still turn back the rising tide of these killers among us.
Episode 8: How to Buy a Cure
By Rebecca Spalding and Michelle Cortez
Some patients can't wait for pharmaceutical companies to develop drugs. They're pushing the drug industry to make the cures they and their loved ones need. But what's good for patients is also good for pharma's profits, creating a web of murky incentives that makes the issue of high drug costs all the more difficult to parse. In episode 8 of the Prognosis podcast, Bloomberg's Rebecca Spalding talks to these professional patients about their relationships to the big companies whose therapies they need.
Episode 7: Dying, Desperate Patients Get the Right to Try Unproven Cures
By Michelle Cortez
Should a patient dying of a disease with no proven cure have the right to try whatever experimental drug they want? A controversial new law signed by President Trump this year says that they should, bypassing the FDA. In episode seven, Bloomberg's Michelle Fay Cortez explores what the new Right To Try law means for desperate patients who want access to experimental treatments. It isn't as simple as it sounds.
Episode 6: One Drug's $2.5 Billion Journey from Lab to Market
By Rebecca Spalding and Michelle Cortez
Bloomberg's Rebecca Spalding tells the surprising journey of one life-saving drug, from discovery to market. It's a story about a Nobel Prize winner, cutting edge genetic research, billions of pharmaceutical dollars, and of all things, a worm. What does it tell us about health care in America?
Frog Hacking Illo
By Kristen V Brown and Michelle Cortez
Today we'll take you on a tour of a biohacker's DNA experiment to change how frogs—and possibly people—grow muscles. It's an experiment which he insists anyone can try at home. He'll even sell you a kit—frogs included—to do it